| 000 | 01753 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517081610.0 | ||
| 264 | 0 | _c20161104 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a1080-6059 | ||
| 024 | 7 |
_a10.3201/eid2203.151130 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenry, Benoît | |
| 245 | 0 | 0 |
_aPreliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014. _h[electronic resource] |
| 260 |
_bEmerging infectious diseases _cMar 2016 |
||
| 300 |
_a518-21 p. _bdigital |
||
| 500 | _aPublication Type: Historical Article; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aExtensively Drug-Resistant Tuberculosis _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHistory, 21st Century |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRevest, Matthieu | |
| 700 | 1 | _aDournon, Nathalie | |
| 700 | 1 | _aEpelboin, Loïc | |
| 700 | 1 | _aMellon, Guillaume | |
| 700 | 1 | _aBellaud, Guillaume | |
| 700 | 1 | _aMordant, Pierre | |
| 700 | 1 | _aLe Dû, Damien | |
| 700 | 1 | _aVéziris, Nicolas | |
| 700 | 1 | _aBernard, Christine | |
| 700 | 1 | _aMorel, Sébastien | |
| 700 | 1 | _aJauréguiberry, Stéphane | |
| 700 | 1 | _aMichelet, Christian | |
| 700 | 1 | _aBricaire, Françcois | |
| 700 | 1 | _aTattevin, Pierre | |
| 700 | 1 | _aCaumes, Éric | |
| 773 | 0 |
_tEmerging infectious diseases _gvol. 22 _gno. 3 _gp. 518-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3201/eid2203.151130 _zAvailable from publisher's website |
| 999 |
_c25746507 _d25746507 |
||